Skip to main content

Table 2 Expression of ER, PR and HER2 in cases and distribution of breast cancer molecular subtypes

From: Breast cancer in togolese women: immunohistochemistry subtypes

Variables Number of patients (%)
Estrogen receptor status  
Positive 64 (54.7)
Negative 53 (45.3)
Progesterone receptor status  
Positive 48 (41)
Negative 69 (59)
HER2 Status  
Positive 18 (15.4)
Negative 99 (84.6)
Molecular subtype  
Luminal A 36 (30.8)
Luminal B 28 (23.9)
Triple Negative 44 (37.6)
HER2 enriched 9 (7.7)